Anti-Apolipoprotein A V/APOA5 antibody [EPR25738-68]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal Apolipoprotein A V/APOA5 antibody. Suitable for WB, IP and reacts with Human samples.
View Alternative Names
RAP3, UNQ411/PRO773, APOA5, Apolipoprotein A-V, Apo-AV, ApoA-V, Apolipoprotein A5, Regeneration-associated protein 3
- IP
Supplier Data
Immunoprecipitation - Anti-Apolipoprotein A V/APOA5 antibody [EPR25738-68] (AB313368)
Apolipoprotein A V/APOA5 was immunoprecipitated from 0.35 mg HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate with ab313368 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab313368 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate
Lane 2 : ab313368 IP in HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab313368 in HepG2 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 180 seconds.
All lanes:
Immunoprecipitation - Anti-Apolipoprotein A V/APOA5 antibody [EPR25738-68] (ab313368) at 1/1000 dilution
All lanes:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 14 kDa
Observed band size: 15 kDa
false
- WB
Supplier Data
Western blot - Anti-Apolipoprotein A V/APOA5 antibody [EPR25738-68] (AB313368)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Negative control : skeletal muscle, lung (PMID : 11577099), HeLa, THP-1 (PMID : 21489765). The blot of lane 5 was developed using a high sensitivity ECL substrate. In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200, 000 dilution. Exposure time : Lanes 1-4 : 92 seconds; Lane 5 : 180 seconds; Lanes 6-8 : 92 seconds.
All lanes:
Western blot - Anti-Apolipoprotein A V/APOA5 antibody [EPR25738-68] (ab313368) at 1/1000 dilution
Lane 1:
Human plasma at 20 µg
Lane 2:
Human serum at 20 µg
Lane 3:
Human skeletal muscle tissue lysate at 20 µg
Lane 4:
Human lung tissue lysate at 20 µg
Lane 5:
Human liver tissue lysate at 20 µg
Lane 6:
HepG2 (human hepatocellar carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 7:
THP-1 (human monocytic leukemia monocyte) whole cell lysate at 20 µg
Lane 8:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
Lanes 1 - 5:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Lanes 6 - 8:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 41 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
APOA5 influences triglyceride metabolism and is part of the HDL particle complex. It interacts directly with lipoprotein lipase to promote the hydrolysis of triglycerides into free fatty acids. This hydrolytic action aids in reducing triglyceride levels in the plasma. APOA5 also indirectly influences very-low-density lipoprotein (VLDL) metabolism reinforcing its role in lipid regulation.
Pathways
APOA5 integrates into the lipoprotein metabolic pathway and the PPAR signaling pathway. In the lipoprotein metabolic pathway APOA5 works with proteins like APOC3 to influence triglyceride homeostasis. This protein is modulated by PPAR-alpha helping control lipid metabolism and energy homeostasis. Its role in these pathways highlights its impact on triglyceride-rich lipoprotein metabolism positioning it as an important player in maintaining lipid balance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com